Advertisement

Index by author

March 01, 1994; Volume 22,Issue 2

  1. Dwyer, L M

    1. In vitro metabolism of L-696,229, an HIV-1 reverse transcriptase inhibitor in rats and humans. Hepatic and extrahepatic metabolism and identification of enzymes involved in the hepatic metabolism.
      T Prueksaritanont, L M Dwyer, S K Balani and A D Theoharides
      Drug Metabolism and Disposition March 1994, 22 (2) 281-288;

  2. East, P

    1. Use of rat and human in vitro systems to assess the effectiveness and enzymology of deoxyguanine analogs as prodrugs of an antiviral agent.
      A W Harrell, S M Wheeler, P East, S E Clarke and R J Chenery
      Drug Metabolism and Disposition March 1994, 22 (2) 189-193;

  3. Egorin, M J

    1. Effect of cimetidine, probenecid, and ketoconazole on the distribution, biliary secretion, and metabolism of [3H]taxol in the Sprague-Dawley rat.
      R W Klecker, C A Jamis-Dow, M J Egorin, K Erkmen, R J Parker, R Stevens and J M Collins
      Drug Metabolism and Disposition March 1994, 22 (2) 254-258;

  4. Erkmen, K

    1. Effect of cimetidine, probenecid, and ketoconazole on the distribution, biliary secretion, and metabolism of [3H]taxol in the Sprague-Dawley rat.
      R W Klecker, C A Jamis-Dow, M J Egorin, K Erkmen, R J Parker, R Stevens and J M Collins
      Drug Metabolism and Disposition March 1994, 22 (2) 254-258;

  5. Faiman, M D

    1. NADPH-dependent, regioselective S-oxidation of a thionosulfur- and thioether-containing xenobiotic, diethyldithiocarbamate methyl ester by rat liver microsomes.
      A Madan and M D Faiman
      Drug Metabolism and Disposition March 1994, 22 (2) 324-330;

  6. Fischer, V

    1. The polymorphic cytochrome P-4502D6 is involved in the metabolism of both 5-hydroxytryptamine antagonists, tropisetron and ondansetron.
      V Fischer, A E Vickers, F Heitz, S Mahadevan, J P Baldeck, P Minery and R Tynes
      Drug Metabolism and Disposition March 1994, 22 (2) 269-274;

  7. Forkert, P G

    1. Induction and regulation of CYP2E1 in murine liver after acute and chronic acetone administration.
      P G Forkert, Z M Redza, S Mangos, S S Park and S P Tam
      Drug Metabolism and Disposition March 1994, 22 (2) 248-253;

  8. Garbow, J R

    1. Milacemide metabolism in rat liver and brain slices by solids NMR.
      J R Garbow, W P Ridley, V Bork, Y Pan and J Schaefer
      Drug Metabolism and Disposition March 1994, 22 (2) 298-303;

  9. Garland, W A

    1. Disposition of [14C]acitretin in humans following oral administration.
      F Rubio, B K Jensen, L Henderson, W A Garland, A Szuna and C Town
      Drug Metabolism and Disposition March 1994, 22 (2) 211-215;

  10. Goldman, M E

    1. Metabolism of 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2 (1H)-one (L-696,229), an HIV-1 reverse transcriptase inhibitor, by rat liver slices and in humans.
      S K Balani, L R Kauffman, B H Arison, T V Olah, M E Goldman, S L Varga, J A O'Brien, H G Ramjit, C S Rooney and J M Hoffman
      Drug Metabolism and Disposition March 1994, 22 (2) 200-205;
« Previous (Pages : 1 2 3 4 5 6 7 8 ... 12) Next »
Back to top

In this issue

Advertisement